The authors of An additional paper described the administration of HBOT as adjuvant therapy for acute macular neuroretinopathy in systemic lupus erythematosus in conjunction with immunosuppression in two patients [11].We only use high-quality, credible sources to be certain information precision and integrity. It is possible to find out more regard